FDA says adults on anti-depressants must be closely ...

[Guest guest]

All anyone has to do is join 3 Groups and they will quickly know about the "dangerous side effects" of SSRI's from adults and survivors of SSRI victims. See:

SSRI-Crusaders-

Withdrawal_and_Recovery-

SSRI-Research-

 

Just me...... Jan

===============================

..

In a message dated 7/4/2005 10:36:27 A.M. Central Daylight Time, oneplanet4life writes:

Oh my gosh, check this out!!!!Source of info: http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01362.html What a laugh, their a bunch of idiots!!!!FDA Talk PaperT05-25July 1, 2005 Media Inquiries:Laura Alvey, 301-827-6242Consumer Inquiries:888-INFO-FDAFDA Reviews Data for Antidepressant Use in AdultsIn response to recent scientific publications thatreport the possibility of increased risk of suicidalbehavior in adults treated with antidepressants, theU.S. Food and Drug Administration (FDA) has issued aPublic Health Advisory (PHA) to update patients andhealthcare providers with the latest information onthis subject.Even before the publication of these recent reports,FDA had already begun the process of reviewingavailable data to determine whether there is anincreased risk of suicidal behavior in adults takingantidepressants. The Agency has asked manufacturers toprovide information from their trials using anapproach similar to that used in the evaluation of therisk of suicidal behavior in the pediatric populationtaking antidepressants. This effort will involvehundreds of clinical trials and may take more than ayear to complete.In the meantime, the PHA advises health care providersand patients to be aware of the following: * Adults being treated with antidepressantmedicines, particularly those being treated fordepression, should be watched closely for worsening ofdepression and for increased suicidal thinking orbehavior. * Close observation of adults may be especiallyimportant when antidepressant medications are startedfor the first time or when doses for the specificdrugs prescribed have been changed. * Adults whose symptoms worsen while being treatedwith antidepressants, including an increase insuicidal thinking or behavior, should be evaluated bytheir health care professional.These recommendations are consistent with warningsalready present in approved labeling forantidepressants used by adults.FDA will provide updated information as it becomesavailable. The Public Health Advisory is available online at http://www.fda.gov/cder/drug/advisory/SSRI200507.htm.